
Transactions: Healthcare
Filter


Initial public offering of Q-linea AB (SE) on Nasdaq Stockholm — SEK 550 million

Initial public offering of Y-mAbs Therapeutics, Inc. (US) on NASDAQ Global Select Market — USD 96 million

Directed new share issue in Camurus AB (SE) — SEK 102 million

Directed new share issue in Lifecare AS (NO) — NOK 31 million

Private placement of shares in Q-linea AB (SE) — SEK 151.5 million

Directed new share issue in Biotec Pharmacon ASA (NO) — NOK 23 million

Initial public offering of Calliditas Therapeutics AB (SE) on Nasdaq Stockholm — SEK 747 million

Directed new share issue in CELLINK AB (SE) — SEK 100 million

Directed new share issue in Nuevolution AB (SE) — SEK 110 million

Block trade of shares in Terveystalo Plc (FI) — EUR 145 million
